@ARTICLE{
author={Cohen Stanley B,...,Damjanov Nemanja S,...,(broj koautora 18)},
year={2020},
title={Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, PhaseIITrial},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={72},
number={9},
pages={1435-1446},
document_type={Article},
} 

@ARTICLE{
author={Smolen Josef S,Pangan Aileen L,Emery Paul,Rigby William,Tanaka Yoshiya,Vargas Juan Ignacio,Zhang Ying,Damjanov Nemanja S,Friedman Alan,Othman Ahmed A,Camp Heidi S,Cohen Stanley B},
year={2019},
title={Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study},
journal={LANCET},
volume={393},
number={10188},
pages={2303-2311},
document_type={Article},
} 

@ARTICLE{
author={Cohen Stanley B,Cheng Tien-Tsai,Chindalore Vishala,Damjanov Nemanja S,Burgos-Vargas Ruben,DeLora Patricia,Zimany Kathleen,Travers Helen,Caulfield John P},
year={2009},
title={Evaluation of the Efficacy and Safety of Pamapimod, a p38 MAP Kinase Inhibitor, in a Double-Blind, Methotrexate-Controlled Study of Patients With Active Rheumatoid Arthritis},
journal={ARTHRITIS AND RHEUMATISM},
volume={60},
number={2},
pages={335-344},
document_type={Article},
}